These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6671924)

  • 21. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
    Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
    Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of biliary tract infection (XXXII)--Excretion into bile, tissue level of the gallbladder and clinical effects of norfloxacin for biliary tract infections].
    Tanimura H; Yoshida K; Kobayashi N; Uchiyama K; Usui Y; Nishimura N; Ozawa K; Kitamura T; Izukura K; Tamura H
    Kansenshogaku Zasshi; 1987 Jun; 61(6):681-703. PubMed ID: 3119741
    [No Abstract]   [Full Text] [Related]  

  • 23. [1st clinical experiments with a new antibiotic, gentamicin].
    Pardelli G
    Minerva Med; 1967 Nov; 58(95 Suppl):4232-5. PubMed ID: 6082384
    [No Abstract]   [Full Text] [Related]  

  • 24. Listeria monocytogenes-associated biliary tract infections: a study of 12 consecutive cases and review.
    Charlier C; Fevre C; Travier L; Cazenave B; Bracq-Dieye H; Podevin J; Assomany D; Guilbert L; Bossard C; Carpentier F; Cales V; Leclercq A; Lecuit M
    Medicine (Baltimore); 2014 Oct; 93(18):e105. PubMed ID: 25319439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary tract infections: a guide to drug treatment.
    Westphal JF; Brogard JM
    Drugs; 1999 Jan; 57(1):81-91. PubMed ID: 9951953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and clinical studies of fosfomycin in bile duct infections].
    Bando T; Toyoshima H
    Jpn J Antibiot; 1984 Jul; 37(7):1279-88. PubMed ID: 6492391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the potency of action of several choleretics].
    Mörsdorf K; Wolf G
    Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421
    [No Abstract]   [Full Text] [Related]  

  • 28. Penetration of antibiotics into bile.
    Mashimo K
    Scand J Infect Dis Suppl; 1978; (14):172-6. PubMed ID: 360372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with Rifamycin SV].
    Angerer M; Pexa H; Neumayr A
    Wien Med Wochenschr; 1966 Dec; 116(51):1127-31. PubMed ID: 5340059
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic aspects of functional symptoms of the upper abdomen in biliary tract diseases].
    Ardjah H
    Fortschr Med Suppl; 1991; 115():2-8. PubMed ID: 1813372
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gram-negative hepatobiliary infections].
    Bernuau J; Rueff B
    Rev Prat; 1983 Jan; 33(3):107-12. PubMed ID: 6844819
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental and clinical evaluation of methacycline (Rondomycin) for biliary tract infections].
    Iwata T; Kon T; Kume Y; Fujisawa J; Kakita A
    J Antibiot B; 1967 Dec; 20(6):420-3. PubMed ID: 5301339
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria and disease of the biliary tract.
    Scott AJ
    Gut; 1971 Jun; 12(6):487-92. PubMed ID: 4933136
    [No Abstract]   [Full Text] [Related]  

  • 35. Septicemia from biliary tract infection.
    Siegman-Igra Y; Schwartz D; Konforti N; Perluk C; Rozin RR
    Arch Surg; 1988 Mar; 123(3):366-8. PubMed ID: 3341915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical studies on apalcillin in biliary tract infections (author's transl)].
    Mishima K; Ohta T; Kitagawa N; Harada H
    Jpn J Antibiot; 1979 Sep; 32(9):960-5. PubMed ID: 501923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness of using decamethoxine in chronic gastritis and gastroduodenitis combined with biliary tract diseases].
    Mokhun' IK; Vladkovskiĭ IK; Luk'ianchuk DG; Shubravskiĭ AA; Gaĭdukov VA
    Vrach Delo; 1982 Apr; (4):23-6. PubMed ID: 7101851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibiotic therapy in cholecystitis, cholangitis and pancreatitis].
    Lubasch A; Lode H
    Internist (Berl); 2000 Feb; 41(2 Pt 1):168-74. PubMed ID: 10743597
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
    Koizumi M; Simosegawa T; Yanbe M; Goto Y; Sugawara H; Kanno Y; Kanazawa Y; Kai Y; Sato T; Endou K
    Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of biliary tract dyskinesia and inflammation in viral hepatitis].
    Andreĭchin MA; Kiĭko LG
    Vrach Delo; 1983 May; (5):112-5. PubMed ID: 6880156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.